Meadow Creek Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$14.5M Buy
228,140
+48,552
+27% +$3.17M 0.28% 74
2019
Q2
$12.1M Buy
179,588
+32,640
+22% +$2.15M 0.24% 89
2019
Q1
$9.55M Buy
146,948
+11,118
+8% +$739K 0.19% 102
2018
Q4
$8.5M Sell
135,830
-5,576
-4% -$390K 0.2% 107
2018
Q3
$10.9M Sell
141,406
-341,700
-71% -$25.8M 0.22% 106
2018
Q2
$34.2M Sell
483,106
-4,046
-0.8% -$286K 0.72% 26
2018
Q1
$36.7M Buy
487,152
+109,072
+29% +$8.67M 0.8% 23
2017
Q4
$27.1M Sell
378,080
-8,806
-2% -$669K 0.59% 30
2017
Q3
$31.3M Sell
386,886
-41,718
-10% -$3.19M 0.73% 25
2017
Q2
$30.3M Sell
428,604
-178,840
-29% -$11.9M 0.72% 31
2017
Q1
$41.3M Sell
607,444
-466,752
-43% -$32.8M 1% 20
2016
Q4
$76.9M Buy
+1,074,196
New +$79.8M 1.99% 8

Other funds holding GILD

Meadow Creek Investment Management's GILD Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Gilead Sciences (GILD) stake by 27% in Q3 2019, buying an estimated $3.17M and bringing the position to 228,140 shares worth $14.5M. The position accounts for 0.28% of the portfolio, ranked #74.

Meadow Creek Investment Management first reported a position in GILD in Q4 2016 and has held it in 12 quarters since. The position peaked at $76.9M in Q4 2016. 1,463 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Meadow Creek Investment Management held 228,140 shares of Gilead Sciences worth $14.5M as of Q3 2019.
  • Meadow Creek Investment Management bought 48,552 Gilead Sciences shares in Q3 2019, an estimated $3.17M.
  • Gilead Sciences made up 0.28% of Meadow Creek Investment Management's portfolio in Q3 2019, its #74 holding.
  • Meadow Creek Investment Management first reported a position in Gilead Sciences in Q4 2016 and has held it in 12 quarters since.
  • Meadow Creek Investment Management's Gilead Sciences position peaked at $76.9M in Q4 2016.
  • 1,463 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.